(7-028) Assessing the Real-World Impact of Adalimumab Biosimilar Transition in Stable Irritable Bowel Disease (IBD) Patients: A Three-Month Outcome Analysis
Tuesday, December 9, 2025
12:00 PM - 1:00 PM
Location: Bayside A, Level 1
Pharmacy School: Lipscomb University College of Pharmacy Pharmacy School Location: Tennessee
Co-Author(s): Danielle Baird, Autumn Zuckerman, Josh DeClercq, Chelsea Renfro
